Acute Lymphoblastic Leukemia, With Appropriate Mutations

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Acute Lymphoblastic Leukemia, With Appropriate Mutations trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

AVAILABLENot Applicable

NCT05738538

Expanded Access to Ziftomenib

Requests for single patient expanded access to ziftomenib monotherapy may be considered for eligible adult patients with Acute Lymphoblastic Leukemia (ALL) with…

Location not specified

Treatment: ziftomenib